Subject Selection and Management in Bioequtvalence Studies
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Clinical Research and Regulatory Affairs
- Vol. 9 (2) , 71-87
- https://doi.org/10.3109/10601339209005328
Abstract
This article summarizes the criteria for selection of subjects to participate in bioequivalence studies and the management of these subjects while the study is in progress. Factors such as gender, age, body size, nutritional status, tobacco use, disease states, concurrent drug use, and substance abuse must be considered to identify a suitable subject population in which the product formulations, and not intersubject variations, will be the only significant determinants of bioequivalence. Fluid and food intake, physical activity, and consumption of certain dietary products must be carefully restricted during the study course so that these factors will not influence drug absorption or elimination.Keywords
This publication has 14 references indexed in Scilit:
- Clinical Pharmacokinetic Considerations in the ElderlyClinical Pharmacokinetics, 1989
- Recent Developments in the Study of the Effects of Cigarette Smoking on Clinical Pharmacokinetics and Clinical PharmacodynamicsClinical Pharmacokinetics, 1989
- Guide to Drug Dosage in Hepatic Disease1Clinical Pharmacokinetics, 1988
- Guide to Drug dosage in Renal Failure1Clinical Pharmacokinetics, 1988
- Influences of Diet and Nutrition on Clinical PharmacokineticsClinical Pharmacokinetics, 1988
- Drug Disposition in Obese HumansClinical Pharmacokinetics, 1986
- Effects of Ethanol on Drug and Metabolite PharmacokineticsClinical Pharmacokinetics, 1985
- Effect of Acute and Chronic Exercise on Hepatic Drug MetabolismClinical Pharmacokinetics, 1985
- Effects of physical activity and immobilization on plasma digoxin concentration and renal digoxin clearanceClinical Pharmacology & Therapeutics, 1983
- Influence of Sex on Drug Kinetics in ManClinical Pharmacokinetics, 1977